Literature DB >> 22249698

[Microwave tumor ablation. New devices, new applications?].

R Hoffmann1, H Rempp, S Clasen.   

Abstract

CLINICAL ISSUE: The majority of patients with hepatic malignancies are not amenable to surgical resection. In some of these cases minimally invasive ablative therapies are a treatment option. STANDARD TREATMENT: Besides radiofrequency ablation, the most common ablative therapies are cryoablation, laser ablation and microwave ablation. TREATMENT INNOVATIONS: The classic fields of application of microwave ablation are the treatment of malignancies of the liver, kidneys and lungs. Furthermore, cases of treatment of bone tumors and tumors of the adrenal gland have been reported as well as treatment of secondary hypersplenism. PERFORMANCE: The manufacturers of microwave systems pursue different strategies to reach an optimal ablation zone, such as water or gas cooling of the antenna, the simultaneous use of different antennas or an automatic modulation of the microwave energy and frequency. ACHIEVEMENTS: In contrast to other tumor ablation methods microwave ablation causes a direct heating of a tissue volume, thus this method is less vulnerable to the cooling effect of vessels in the ablation zone. Moreover the electric conductivity of the treated tissue does not influence microwave radiation so that microwave ablation has advantages for the treatment of high-resistance organs, such as the lungs or bone. Some publications have shown that microwave ablation causes larger ablation zones in less time in comparison to radiofrequency ablation. PRACTICAL RECOMMENDATIONS: Classic indications for microwave ablation are the treatment of malignancies of the liver, lungs and kidneys. Initial technical problems have been solved, so that an increasing significance of the microwave ablation among the ablative therapies is to be expected.

Entities:  

Mesh:

Year:  2012        PMID: 22249698     DOI: 10.1007/s00117-011-2208-9

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  30 in total

1.  Radiofrequency versus microwave ablation in a hepatic porcine model.

Authors:  Andrew S Wright; Lisa A Sampson; Thomas F Warner; David M Mahvi; Fred T Lee
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

2.  Effects of blood flow and/or ventilation restriction on radiofrequency coagulation size in the lung: an experimental study in swine.

Authors:  Hiroshi Anai; Barry T Uchida; Dusan Pavcnik; Chang Kyu Seong; Phillip Baker; Luiz Otavio Correa; Christopher L Corless; Serdar Geyik; Kivilcim Yavuz; Hiroshi Sakaguchi; Kimihiko Kichikawa; Frederick S Keller; Josef Rösch
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Sep-Oct       Impact factor: 2.740

3.  Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings.

Authors:  Michael M Awad; Lara Devgan; Ihab R Kamel; Michael Torbensen; Michael A Choti
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

4.  Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model.

Authors:  Christopher L Brace; J Louis Hinshaw; Paul F Laeseke; Lisa A Sampson; Fred T Lee
Journal:  Radiology       Date:  2009-03-31       Impact factor: 11.105

5.  Comparison of microwave ablation and multipolar radiofrequency ablation, both using a pair of internally cooled interstitial applicators: results in ex vivo porcine livers.

Authors:  Xin Li; Liang Zhang; Weijun Fan; Ming Zhao; Ligang Wang; Tian Tang; Hua Jiang; Jianlei Zhang; Yanfeng Liu
Journal:  Int J Hyperthermia       Date:  2011       Impact factor: 3.914

Review 6.  Microwave tumor ablation: mechanism of action, clinical results, and devices.

Authors:  Meghan G Lubner; Christopher L Brace; J Louis Hinshaw; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2010-08       Impact factor: 3.464

7.  Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma.

Authors:  T Shibata; T Niinobu; N Ogata; M Takami
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

8.  Initial experience using microwave ablation therapy for renal tumor treatment: 18-month follow-up.

Authors:  Scott M Castle; Nelson Salas; Raymond J Leveillee
Journal:  Urology       Date:  2011-02-16       Impact factor: 2.649

9.  Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients.

Authors:  Farrah J Wolf; David J Grand; Jason T Machan; Thomas A Dipetrillo; William W Mayo-Smith; Damian E Dupuy
Journal:  Radiology       Date:  2008-03-27       Impact factor: 11.105

10.  Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.

Authors:  Xiao-Yu Yin; Xiao-Yan Xie; Ming-De Lu; Hui-Xiong Xu; Zuo-Feng Xu; Ming Kuang; Guang-Jian Liu; Jin-Yu Liang; Wan Yee Lau
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

View more
  5 in total

1.  [Thermoablative therapy of hepatocellular carcinoma. Indications, technique and results].

Authors:  T Hofmockel; V Plodeck; M Laniado; R-T Hoffmann
Journal:  Radiologe       Date:  2014-07       Impact factor: 0.635

Review 2.  Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.

Authors:  Stefan Stättner; Florian Primavesi; Vincent S Yip; Robert P Jones; Dietmar Öfner; Hassan Z Malik; Stephen W Fenwick; Graeme J Poston
Journal:  Surg Today       Date:  2014-03-16       Impact factor: 2.549

3.  [Targeted radiological therapy of liver tumors].

Authors:  F Waneck
Journal:  Radiologe       Date:  2015-01       Impact factor: 0.635

4.  CT-guided navigated microwave ablation (MWA) of an unfavorable located breast cancer metastasis in liver segment I.

Authors:  Tim Fischer; Anja Lachenmayer; Martin Helmut Maurer
Journal:  Radiol Case Rep       Date:  2018-10-30

5.  A prospective randomized trial comparing microwave and radiofrequency ablation for the treatment of liver metastases using a dual ablation system ─ The Mira study.

Authors:  Thomas J Vogl; Yousef Jaraysa; Simon S Martin; Tatjana Gruber-Rouh; Rock H Savage; Nour-Eldin A Nour-Eldin; Amela Mehmedovic
Journal:  Eur J Radiol Open       Date:  2022-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.